These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19297167)

  • 1. The relationship between low bone mineral density and Parkinson's disease in a Korean population.
    Song IU; Kim JS; Lee SB; Ryu SY; An JY; Jeong DS; Kim YI; Lee KS
    J Clin Neurosci; 2009 Jun; 16(6):807-9. PubMed ID: 19297167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density and serum vitamin D status in Parkinson's disease: Are the stage and clinical features of the disease important?
    Ozturk EA; Gundogdu I; Tonuk B; Umay E; Kocer BG; Cakci A
    Neurol India; 2020; 68(2):394-400. PubMed ID: 32415013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density in patients with familial Mediterranean fever.
    Yildirim K; Karatay S; Cetinkaya R; Uzkeser H; Erdal A; Capoglu I; Erdem FH
    Rheumatol Int; 2010 Jan; 30(3):305-8. PubMed ID: 19449009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.
    Lee SH; Kim MJ; Kim BJ; Kim SR; Chun S; Kim HK; Ryu JS; Kim GS; Lee MC; Chung SJ; Koh JM
    Calcif Tissue Int; 2010 Feb; 86(2):132-41. PubMed ID: 20049422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between bone mineral density and blood pressure in the Korean elderly population: the Korea National Health and Nutrition Examination Survey, 2008-2011.
    Lee HT; Shin J; Min SY; Lim YH; Kim KS; Kim SG; Kim JH; Lim HK
    Clin Exp Hypertens; 2015; 37(3):212-7. PubMed ID: 25057784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density.
    Shin CS; Choi HJ; Kim MJ; Kim JT; Yu SH; Koo BK; Cho HY; Cho SW; Kim SW; Park YJ; Jang HC; Kim SY; Cho NH
    Bone; 2010 Aug; 47(2):378-87. PubMed ID: 20362081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone and mineral metabolism in older adults with Parkinson's disease.
    Abou-Raya S; Helmii M; Abou-Raya A
    Age Ageing; 2009 Nov; 38(6):675-80. PubMed ID: 19684354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometry.
    Kao CH; Chen CC; Wang SJ; Chia LG; Yeh SH
    Nucl Med Commun; 1994 Mar; 15(3):173-7. PubMed ID: 8190408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density (BMD) in male patients with Parkinson's disease.
    Daniel SK; Lansang MC; Okun MS
    Int J Neurosci; 2012 Sep; 122(9):523-7. PubMed ID: 22510054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
    J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease and osteoporosis.
    van den Bos F; Speelman AD; Samson M; Munneke M; Bloem BR; Verhaar HJ
    Age Ageing; 2013 Mar; 42(2):156-62. PubMed ID: 23132148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bone mineral density and decreased prevalence of osteoporosis in cervical ossification of the posterior longitudinal ligament: a case-control study.
    Sohn S; Chung CK
    Calcif Tissue Int; 2013 Jan; 92(1):28-34. PubMed ID: 23104450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in patients with Parkinson's Disease.
    Kamanli A; Ardicoglu O; Ozgocmen S; Yoldas TK
    Aging Clin Exp Res; 2008 Jun; 20(3):277-9. PubMed ID: 18594197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of Musculoskeletal Pain with Bone Mineral Density in Patients with Parkinson's Disease.
    Choi SM; Kim BC; Jung HJ; Yoon GJ; Kang KW; Choi KH; Lee SH; Park MS; Kim MK; Cho KH
    Eur Neurol; 2017; 77(3-4):123-129. PubMed ID: 28056455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trunk muscle strength, but not trunk rigidity, is independently associated with bone mineral density of the lumbar spine in patients with Parkinson's disease.
    Pang MY; Mak MK
    Mov Disord; 2009 Jun; 24(8):1176-82. PubMed ID: 19412964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis risk and bone mineral density levels in patients with Parkinson's disease: a meta-analysis.
    Zhao Y; Shen L; Ji HF
    Bone; 2013 Jan; 52(1):498-505. PubMed ID: 23000281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bone mineral density with dual energy x-ray absorptiometry, quantitative ultrasound and single energy x-ray absorptiometry.
    El-Desouki MI; Sherafzal MS; Othman SA
    Saudi Med J; 2005 Sep; 26(9):1346-50. PubMed ID: 16155646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound velocity and attenuation at different skeletal sites compared with bone mineral density measured using dual energy X-ray absorptiometry.
    Cunningham JL; Fordham JN; Hewitt TA; Speed CA
    Br J Radiol; 1996 Jan; 69(817):25-32. PubMed ID: 8785618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss.
    Nguyen TV; Sambrook PN; Eisman JA
    J Bone Miner Res; 1997 Jan; 12(1):124-35. PubMed ID: 9240735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.